| Vial description: |
LR11, SorLA-1, SorLA |
| Category: |
control peptide |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
pure |
| Reactivity: |
not determined |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
Q92673 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
, 2 or 3 and , Freeze thaw will destroy a percentage in every cycle and should be avoided, However, In this sense, Isotype or positive controls by peptides, Peptides short amino acid chains or epitopes or blocking antagonists, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The receptors are ligand binding factors of type 1, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), When such chemical-signals couple or bind to a receptor, a change in the electrical-activity of a cell, acetylcholine, am olfactory receptor is a protein-molecule that recognizes and responds to , an acetylcholine-receptor recognizes and responds to its endogenous-ligand, and unbranched synthetic peptide chains, antibodies and deactivated samples, chemokinesor cytokines e, consisting of 2 amino acids joined by a single peptide bond, continuous, e, followed by tripeptides, or in continue produced for custom peptide synthesis projects, sometimes in pharmacology, such as enzymes, tetra peptides, the term is also used to include other proteins that are drug-targets, they cause some form of cellular/tissue-response, till polypeptides that are long, transporters and ion-channels, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4°, endogenous-chemical signals, g, g, protein-molecules , that receive chemical-signals from outside a cell |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
Sortilin-related receptor (SORL1) peptide |
| Short name: |
anti-Sortilin-related receptor (SORL1) control peptide Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, peptides, Antibody |
| Alternative name: |
L(DLR class) A repeats containing) reference short protein sequence (Antibody to), antibody to-Sortilin-related receptor (sortilin-related receptor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ADP-ribosylation factor binding, C11orf32 and gp250 and LR11 and LRP9 and SORLA and SorLA-1, L(DLR class) A repeats containing, SORL1 and IDBG-632166 and ENSBTAG00000014611 and 533166, SORL1 and IDBG-74757 and ENSG00000137642 and 6653, Sorl1 and IDBG-154026 and ENSMUSG00000049313 and 20660, nuclei, this GO :0000042 and protein targeting to this GO lgi and biological process this GO :0001540 and beta-amyloid binding and molecular function this GO :0004888 and transmembrane signaling receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005641 and nuclear envelope lumen and cellular component this GO :0005768 and endosome and cellular component this GO :0005769 and early endosome and cellular component this GO :0005771 and multivesicular body and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005802 and trans- this GO lgi network and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006605 and protein targeting and biological process this GO :0006622 and protein targeting to lysosome and biological process this GO :0006869 and lipid transport and biological process this GO :0006892 and post- this GO lgi vesicle-mediated transport and biological process this GO :0006898 and receptor-mediated endocytosis and biological process this GO :0007165 and signal transduction and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0008219 and cell death and biological process this GO :0008283 and cell proliferation and biological process this GO :0014910 and regulation of smooth muscle cell migration and biological process this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0016477 and cell migration and biological process this GO :0030169 and low-density lipoprotein particle binding and molecular function this GO :0030306 and ADP-ribosylation factor binding and molecular function this GO :0031985 and this GO lgi cisterna and cellular component this GO :0032091 and negative regulation of protein binding and biological process this GO :0032460 and negative regulation of protein oli this GO merization and biological process this GO :0034362 and low-density lipoprotein particle and cellular component this GO :0043025 and neuronal cell body and cellular component this GO :0043407 and negative regulation of MAP kinase activity and biological process this GO :0045053 and protein retention in this GO lgi apparatus and biological process this GO :0045732 and positive regulation of protein catabolic process and biological process this GO :0050768 and negative regulation of neurogenesis and biological process this GO :0051604 and protein maturation and biological process this GO :0055037 and recycling endosome and cellular component this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070863 and positive regulation of protein exit from endoplasmic reticulum and biological process this GO :1901215 and negative regulation of neuron death and biological process this GO :1902430 and negative regulation of beta-amyloid formation and biological process this GO :1902771 and positive regulation of choline O-acetyltransferase activity and biological process this GO :1902948 and negative regulation of tau-protein kinase activity and biological process this GO :1902953 and positive regulation of ER to this GO lgi vesicle-mediated transport and biological process this GO :1902955 and positive regulation of early endosome to recycling endosome transport and biological process this GO :1902960 and negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process and biological process this GO :1902963 and negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process and biological process this GO :1902966 and positive regulation of protein localization to early endosome and biological process this GO :1902997 and negative regulation of neurofibrillary tangle assembly and biological process this GO :2001137 and positive regulation of endocytic recycling and biological process, this GO :0001540 : beta-amyloid binding, this GO :0001540 : beta-amyloid binding and also this GO :0004888 : transmembrane signaling receptor activity and also this GO :0005515 : protein binding and also this GO :0030169 : low-density lipoprotein particle binding and also this GO :0030306 : ADP-ribosylation factor binding, this GO :0004888 : transmembrane signaling receptor activity, this GO :0005515 : protein binding, this GO :0030169 : low-density lipoprotein particle binding, this GO :0030306 : ADP-ribosylation factor binding, sortilin-related receptor |
| Identity: |
3829 |
| Gene: |
FRA10A |
More about : FRA10A |
| Long gene name: |
folic acid type, fra(10)(q23, fragile site, rare, 2) , 3) or fra(10)(q24 |
| Locus: |
10q23, 2 , 3 or 10q24 |
| Discovery year: |
1986-01-01 |
| Pubmed identfication: |
15203205 |